School of Biosciences

Join us in our journey of discovery


profile image for Dr Dan Lloyd

Dr Dan Lloyd

Professor in Pharmacology/Deputy Head of School

School of Biosciences


Dr Dan Lloyd joined the School of Biosciences in 2001 as a Lecturer. After a degree in Chemistry at the University of York, he completed his PhD at the Institute of Cancer Research in London and 3 years as a postdoctoral fellow at Stanford University in California, before taking up his position at Kent. As a member of the Cell Biology, Cancer Targets and Therapies Group, research interests relate to the cellular response to DNA damage induced by environmental and clinical agents, and how this relates to human health, disease and therapy. Dr Lloyd was also recently awarded a National Teaching Fellowship from the Higher Education Academy for his work on science communication final year projects.

ORCID ID: 0000-0002-4888-6790

back to top

Also view these in the Kent Academic Repository

Saintas, E. et al. (2017). Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS. PLoS ONE [Online] 12:e0172140. Available at:
Popay, A. et al. (2017). Dexamethasone for the Prevention of Cisplatin-induced Ototoxicity. Clinical Cancer Drugs [Online] 4:59-64. Available at:
Weeks, A., Blower, P. and Lloyd, D. (2013). p53-dependent radiobiological responses to internalised indium-111 in human cells. Nuclear Medicine and Biology [Online] 40:73-79. Available at:
Weeks, A. et al. (2010). Radiobiological effects of hypoxia-dependent uptake of (64)Cu-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells. European Journal of Nuclear Medicine and Molecular Imaging [Online] 37:330-338. Available at:
Bhana, S. et al. (2008). p53-dependent global nucleotide excision repair of cisplatin-induced intrastrand cross links in human cells. Mutagenesis [Online] 23:131-136. Available at:
Bhana, S. and Lloyd, D. (2008). The role of p53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts. Mutagenesis [Online] 23:43-50. Available at:
Book section
Lloyd, D. (2010). Evaluation of radiopharmaceuticals using cell culture models. in: Theobald, T. ed. Sampson's Textbook of Radiopharmacy. Pharmaceutical Press, pp. 605-615.
Lloyd, D. (2008). Final year research projects in communicating science. in: Luck, M. and Wilson, J. eds. Student Research Projects: Guidance on Practice in the Biosciences. Higher Education Academy, pp. 54-56. Available at:
Show / exhibition
Sleigh, C. and Lloyd, D. (2013). Chain Reaction! [mixed artistic media].
Internet publication
Lloyd, D. (2015). When art and science collide.. [Blog]. Available at:
Showing 10 of 17 total publications in KAR. [See all in KAR]


back to top


DNA damage and repair

Research interests relate to the cellular responses to DNA damage, with particular emphasis on the repair of DNA damage in human cells induced by environmental and clinical agents. More recently we have applied this understanding to the evaluation of novel radiopharmaceuticals used in the imaging treatment of cancer, and to understanding pathways of cancer drug resistance.

Public engagement

Beyond the laboratory, interests relate to the development of creative opportunities for public engagement. A pioneer of science communication training in undergraduate degrees through final year research projects - resulting in a National Teaching Fellowship - interests focus particularly on the intersection of science and the arts. Recent public engagement developments have included Chain Reaction (a gallery exhibition marking 30 years of PCR), the Cocktail Laboratory (a science-themed interactive cocktail party) and Cellular Dynamics (an installation at the intersection of science and music).

Dan Lloyd is director of the science strand of the Canterbury Festival and also acts as a Board Member. He is a Senior Fellow of the Higher Education Academy and Fellow of the Royal Society of Biology.

back to top

Year 2

  • BI514 - Pharmacology (Module convenor)
  • BI639 - Frontiers in Oncology
  • BI642 - Cancer Biology


  • BI830 - Science at work (Module convenor)
  • BI835 - Science Communication and Society Project (Module convenor)
  • BI838 - Genomic Stability and Cancer (Module convenor)
  • BI857 - Cancer Research in Focus

National Teaching Fellow

Senior Fellow, Higher Education Academy

Fellow, Royal Society of Biology


Director of Graduate Studies (Taught)

Director, Biotechnology Summer School

back to top

Enquiries: Phone: +44 (0)1227 823743

School of Biosciences, University of Kent, Canterbury, Kent, CT2 7NJ

Last Updated: 23/10/2018